how many people on glp 1 use GLP-1s to lose weight, treat type 2 diabetes, and/or manage other long-term health conditions. And while these drugs are pretty dang effective, it's important that they're paired with certain GLP-1 medications for obesity treatment

potency ratios vs native peptide (GIP 8.9 more potent than native, GLP-1 2.5 less potent, glucagon 2.9 less potent)

Non-approved peptides including Epitalon, GHK-Cu, BPC-157, and the GH secretagogues lack long-term human safety data from large trials

Glossary APAP Acetaminophen ALF acute liver failure NAPQI N-acetyl-p-benzoquinoneimide NAC N-acetylcysteine AILI APAP-induced liver injury COX cyclooxygenase GPX glutathione peroxidase CYP450 cytochrome P450 system ROS reactive oxygen species HO-1 heme oxygenase 1 iNOS inducible nitric oxide synthase CDK4 cyclin-dependent kinase 4 SIRT1 Sirtuin 1 TNF- tumor necrosis factor- AIF apoptosis-inducing factor PI3K phosphoinositide 3-kinase PKC protein kinase C ASK1 apoptosis signal-regulated kinase 1 NQO1 NAD(P)H quinone dehydrogenase 1 SOD superoxide dismutase CAT catalase GSTA2 glutathione S-transferase 2 PKA protein kinase A GCLC glutamate-cysteine ligase catalytic subunit ALT alanine aminotransferase AST aspartate aminotransferase CREA creatinine UREA urea nitrogen NO nitric oxide MDA malondialdehyde GSH glutathione ALP lkaline phosphatase ALB albumin IL-1 interleukin-1 cGAS cyclic GMP-AMP synthase STING stimulators of interferon gene References 1 AbdullahA.PhernT

Understanding GLP-1 Weight Loss Medications Glucagon-like peptide-1 (GLP-1) receptor agonists have revolutionized obesity treatment, but their benefits extend far beyond simple appetite suppression